CytomX Therapeutics Appoints Dr. Mani Mohindru to Board of Directors

Sesen Bio Submits Completed Biologics License Application to the FDA for Vicineum™ and Has Requested Priority Review

Servier and Celsius Therapeutics Announce Target Discovery Collaboration in Colorectal Cancer

Agios to Focus on Developing and Commercializing Innovative Treatments for Genetically Defined Diseases and Sell Its Oncology Business to Servier for Up to $2 Billion Plus Royalties

Agios Announces Updated Data from Phase 1 Study of Mitapivat, First-in-Class PKR Activator, in Sickle Cell Disease